FirsthandHealth
medRxiv PreprintsInternational20 November 2026

Loss of contractile arteriolar smooth muscle cells and their GLP1R expression in human diabetic kidney disease

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Glucagon-like peptide-1 (GLP-1) receptor agonists slow kidney disease progression in type 2 diabetes, and in the human kidney the receptor is localized mainly to arteriolar smooth muscle. Whether these cells and their receptor are preserved in diabetic kidney disease (DKD) is unknown. We combined single-cell-level spatial transcriptomics of 5,101 genes with registered periodic acid-Schiff histology in kidney biopsies from 28 people with DKD, 102 with other glomerular diseases and 24 living donors, and measured 2,531 arterioles and small arteries. Arteriolar walls in DKD contained about 20% few
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.